Preparation of flavonoid derivatives by dehydration reaction between ethylenediamine compounds and baicalein under mild conditions
A technology for warm and dehydration reaction of baicalein, which is applied in the directions of organic chemistry, drug combination, antitumor drugs, etc., can solve the problems of difficult reuse of catalysts, increase production costs, heavy metal pollution, etc., and achieve easy industrialized production and reduced reaction times. Cycle and cost, low pollution effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Add 1.06g of 1,2-diphenylethylenediamine and 1.35g of baicalein into a three-neck flask filled with 20mL of ethanol solution and stir. The system is heated up to 78°C, reacted for 20 hours, filtered while hot, and the filtrate is directly reconstituted. Crystallized to obtain 1.502 g of red crystals with a yield of 62%.
[0021] The product is detected by nuclear magnetic resonance and single crystal X-ray diffractometer, and the results are as shown in the figure, figure 1 for 1 H NMR (DMSO) spectrum, each peak belongs to complete, there is no obvious impurity peak in the figure, shows that the compound obtained is a pure phase. figure 2 It is the three-dimensional structure projection diagram of the product, and the three-dimensional structure of the product can be obtained intuitively. combine figure 1 , confirming that the high-purity target product 2,3,7-triphenyl-10-hydroxyl-1,2,3,4-tetrahydro-9H-pyrano[2,3-g]quinoxaline- 9-keto.
Embodiment 2
[0023] Add 1.06g of 1,2-diphenylethylenediamine and 1.35g of baicalein into a Erlenmeyer flask filled with 20mL of ethanol solution, shake it to fully dissolve it. Under indoor conditions, it was left standing in a fume hood, and after three days, 1.42 g of red crystals were obtained, with a yield of 59%.
[0024] The product was detected by nuclear magnetic resonance, and it was confirmed that the high-purity target product 2,3,7-triphenyl-10-hydroxyl-1,2,3,4-tetrahydro-9H-pyrano[2,3-g ] quinoxalin-9-one, consistent with the product obtained in Example 1.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


